Yumanity Therapeutics

Business Services · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

40 Guest St Ste 4410, Boston, Massachuse...

Phone Number

(617) 409-5300

Revenue

$5.5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Yumanity Therapeutics

Yumanity Therapeutics is a clinical-stage biopharmaceutical company dedicated to accelerating the revolution in the treatment of neurodegenerative diseases through its scientific foundation and drug discovery platform. Yumanity's drug discovery platform enables the Company to rapidly screen for potential disease-modifying therapies by overcoming the toxicity of misfolded proteins associated with neurogenerative diseases. Yumanity's pipeline consists of programs focused on Parkinson's disease, Lewy body dementia, multi-system atrophy, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), frontotemporal lobar dementia (FTLD), and Alzheimer's disease.Explore more
Popular SearchesYumanity Therapeuticsyumanity therapeutics IncYumanity Therapeutics LLCYumanityYumanity Holdings LLCSIC Code 87,873NAICS Code 54,541Show more

Yumanity Therapeutics Org Chart

PhoneEmail
MS
United States flag for contact location.

Vice President, Development Operations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Yumanity Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Yumanity Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Yumanity Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Yumanity Therapeutics.

Yumanity Therapeutics financials insights

Gather financial insights about Yumanity Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2016

Series A

$45M

2020

Debt

$1M

See All Yumanity Therapeutics's Financials Insights

Yumanity Therapeutics Tech Stack

A closer look at the technologies used by Yumanity Therapeutics

Most Recent Scoops

Left Company
Executive Move
Mergers & Acquisitions (M&A)
Left Company
Executive Move
Layoffs
New Hire
Executive Move
See more scoops

Top Business Services Companies

Frequently Asked Questions Regarding Yumanity Therapeutics

What is Yumanity Therapeutics's official website?
Yumanity Therapeutics's official website is www.yumanity.com
What is Yumanity Therapeutics's Revenue?
Yumanity Therapeutics's revenue is $5.5 Million
What is Yumanity Therapeutics's SIC code?
Yumanity Therapeutics's SIC: 87,873
What is Yumanity Therapeutics's NAICS code?
Yumanity Therapeutics's NAICS: 54,541
How many employees does Yumanity Therapeutics have?
Yumanity Therapeutics has 11-50 employees
What industry does Yumanity Therapeutics belong to?
Yumanity Therapeutics is in the industry of: Business Services, Research & Development
What technology does Yumanity Therapeutics use?
Some of the popular technologies that Yumanity Therapeutics uses are: PHP, MySQL, YouTube, Python
How do I contact Yumanity Therapeutics?
Yumanity Therapeutics contact info: Phone number: (617) 409-5300 Website: www.yumanity.com
What does Yumanity Therapeutics do?

Yumanity Therapeutics is a clinical-stage biopharmaceutical company dedicated to accelerating the revolution in the treatment of neurodegenerative diseases through its scientific foundation and drug discovery platform. Yumanity's drug discovery platform enables the Company to rapidly screen for potential disease-modifying therapies by overcoming th... e toxicity of misfolded proteins associated with neurogenerative diseases. Yumanity's pipeline consists of programs focused on Parkinson's disease, Lewy body dementia, multi-system atrophy, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), frontotemporal lobar dementia (FTLD), and Alzheimer's disease.Read More

Who invested in Yumanity Therapeutics?
Yumanity Therapeutics has 4 investors including PPP, Sanofi-Genzyme BioVentures, Biogen and Dolby Family Ventures.
Is Yumanity Therapeutics a public company?
Yumanity Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Yumanity Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.